Literature DB >> 25488752

Agr2 mediates paracrine effects on stromal fibroblasts that promote invasion by gastric signet-ring carcinoma cells.

Tadahiro Tsuji1, Rika Satoyoshi2, Namiko Aiba2, Takanori Kubo3, Kazuyoshi Yanagihara4, Daichi Maeda5, Akiteru Goto5, Kazuo Ishikawa6, Masakazu Yashiro7, Masamitsu Tanaka8.   

Abstract

Agr2 is a disulfide isomerase residing in the endoplasmic reticulum (ER), which physiologically regulates protein folding and mediates resistance to ER stress. Agr2 is overexpressed in adenocarcinomas of various organs, where it participates in neoplastic transformation and metastasis, therefore acts as a pro-oncogenic protein. Besides its normal localization in the ER, Agr2 is also found in the serum and urine of cancer patients, although the physiological significance of extracellular Agr2 is poorly understood. In this study, we demonstrated that extracellular Agr2 can activate stromal fibroblasts and promote fibroblast-associated cancer invasion in gastric signet-ring cell carcinoma (SRCC), where Agr2 is highly expressed. Agr2 secreted from SRCC cells was incorporated by the surrounding gastric fibroblasts and promoted invasion by these cells. In turn, activated fibroblasts coordinated the invasive behavior of fibroblasts and cancer cells. Our findings suggested that Agr2 drives progression of gastric SRCC by exerting paracrine effects on fibroblasts in the tumor microenvironment, acting also to increase the growth and resistance of SRCC cells to oxidative and hypoxic stress as cell autonomous effects. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25488752     DOI: 10.1158/0008-5472.CAN-14-1693

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization.

Authors:  H Guo; Q Zhu; X Yu; S B Merugu; H B Mangukiya; N Smith; Z Li; B Zhang; H Negi; R Rong; K Cheng; Z Wu; D Li
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

Review 2.  Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology.

Authors:  Céline Posseme; Federico Di Modugno; Emeric Boisteau; Julien Edeline; Cédric Coulouarn; Roman Hrstka; Andrea Martisova; Frédéric Delom; Xavier Treton; Leif A Eriksson; Eric Chevet; Astrid Lièvre; Eric Ogier-Denis
Journal:  Oncogene       Date:  2022-09-06       Impact factor: 8.756

3.  Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis.

Authors:  Sophie Vieujean; Shurong Hu; Emeline Bequet; Catherine Salee; Charlotte Massot; Noëlla Bletard; Nicolas Pierre; Florence Quesada Calvo; Dominique Baiwir; Gabriel Mazzucchelli; Edwin De Pauw; Carla Coimbra Marques; Philippe Delvenne; Florian Rieder; Edouard Louis; Marie-Alice Meuwis
Journal:  J Crohns Colitis       Date:  2021-10-07       Impact factor: 9.071

4.  ERp19 contributes to tumorigenicity in human gastric cancer by promoting cell growth, migration and invasion.

Authors:  Jing Wu; Xue-hua Chen; Xin-qiong Wang; Yi Yu; Jian-min Ren; Yuan Xiao; Tong Zhou; Pu Li; Chun-di Xu
Journal:  Oncotarget       Date:  2015-05-20

5.  Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.

Authors:  Joanna Obacz; Veronika Brychtova; Jan Podhorec; Pavel Fabian; Petr Dobes; Borivoj Vojtesek; Roman Hrstka
Journal:  Onco Targets Ther       Date:  2015-06-24       Impact factor: 4.147

6.  Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.

Authors:  Lucia Sommerova; Eva Ondrouskova; Borivoj Vojtesek; Roman Hrstka
Journal:  BMC Cancer       Date:  2017-08-15       Impact factor: 4.430

7.  Extracellular AGR3 regulates breast cancer cells migration via Src signaling.

Authors:  Joanna Obacz; Lucia Sommerova; Daria Sicari; Michal Durech; Tony Avril; Filippo Iuliano; Silvia Pastorekova; Roman Hrstka; Eric Chevet; Frederic Delom; Delphine Fessart
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

8.  ERp29 inhibits tumorigenicity by suppressing epithelial mesenchymal transition in gastric cancer.

Authors:  Jing Wu; Yuanyan Yang; Shenshen Gao; Hong Jiang; Xin-Qiong Wang; Yuan Xiao; Xue-Hua Chen; Pu Li; Chun-Di Xu
Journal:  Oncotarget       Date:  2017-08-12

9.  Cancer-secreted AGR2 induces programmed cell death in normal cells.

Authors:  Elizabeth A Vitello; Sue-Ing Quek; Heather Kincaid; Thomas Fuchs; Daniel J Crichton; Pamela Troisch; Alvin Y Liu
Journal:  Oncotarget       Date:  2016-08-02

10.  Paracrine signalling of AGR2 stimulates RhoA function in fibroblasts and modulates cell elongation and migration.

Authors:  Hitesh Bhagavanbhai Mangukiya; Hema Negi; Siva Bharath Merugu; Qudsia Sehar; Dhahiri Saidi Mashausi; Fakhar-Un-Nisa Yunus; Zhenghua Wu; Dawei Li
Journal:  Cell Adh Migr       Date:  2019-12       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.